US Patent Issued to BASF on July 14 for "Method for preparing an enantiomerically enriched form of 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-apyrimidin-4-ium-5-olate" (German, Indian, Swiss Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,852, issued on July 14, was assigned to BASF SE (Ludwigshafen, Germany).

"Method for preparing an enantiomerically enriched form of 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-apyrimidin-4-ium-5-olate" was invented by Christopher Koradin (Ludwigshafen, Germany), Martin John McLaughlin (Liestal, Switzerland), Roland Goetz (Ludwigshafen, Germany), Rahul Kaduskar (Navi, India) and Harish Shinde (Navi, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for preparing an enantiomerically enriched form of 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrim...